Hamartoma surgery

Jump to navigation Jump to search

Hamartoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamartoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamartoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamartoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamartoma surgery

CDC on Hamartoma surgery

Hamartoma surgery in the news

Blogs on Hamartoma surgery

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [3]

Overview

Surgery is the mainstay of therapy for hamartomas. There are different anatomic approaches for different anatomic sites.

Surgery

Pulmonary Hamartoma

Hypothalamic Hamartoma

  • Hypothalamic hamartomas can be effectively treated with a variety of surgical approaches.
  • The most effective approach is the magnetic resonance imaging (MRI)-guided stereotactic laser ablation (SLA).
  • This approach offers a a potentially safer, minimally invasive method with high efficacy for the hypothalamic hamartoma treatment.[2]
  • Other specific surgical options include; stereotactic thermocoagulation, gamma knife radiosurgery, and physical resection by transsphenoidal microsurgery.
  • Surgery is normally offered if there is a rapid growth of lesion.
  • Surgical response is typically better when the seizure focus has been found by EEG to originate in or near the mass.
  • The specific location of the lesion relative to the pituitary and infundibulum and the amount of hormonal disturbance at presentation can help predict risk of hypopituitarism following surgery.[3]

Cardiac Hamartoma

  • Complete surgical excision is the main choice surgery for symptomatic patients with cardiac hamartoma.
  • Other intervention may be partial excision. However, this procedure is only indicated when the tumor size is more extensive.
  • Postsurgical recurrence is rare.[4]

Kidneys, Spleen, and Other Vascular Organs Hamartomas

References

  1. Guo W, Zhao YP, Jiang YG, Wang RW, Ma Z (2008). "Surgical treatment and outcome of pulmonary hamartoma: a retrospective study of 20-year experience". J. Exp. Clin. Cancer Res. 27: 8. doi:10.1186/1756-9966-27-8. PMC 2438336. PMID 18577258.
  2. Wilfong AA, Curry DJ (2013). "Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis". Epilepsia. 54 Suppl 9: 109–14. doi:10.1111/epi.12454. PMID 24328883.
  3. Pascual-Castroviejo I, Moneo JH, Viaño J, García-Segura JM, Herguido MJ, Pascual Pascual SI (2000). "[Hypothalamic hamartomas: control of seizures after partial removal in one case]". Rev Neurol (in Spanish). 31 (2): 119–22. PMID 10951665.
  4. Bradshaw SH, Hendry P, Boodhwani M, Dennie C, Veinot JP (2011). "Left ventricular mesenchymal hamartoma, a new hamartoma of the heart". Cardiovasc. Pathol. 20 (5): 307–14. doi:10.1016/j.carpath.2010.07.007. PMID 20850353.
  5. Habermalz B, Sauerland S, Decker G, Delaitre B, Gigot JF, Leandros E, Lechner K, Rhodes M, Silecchia G, Szold A, Targarona E, Torelli P, Neugebauer E (2008). "Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES)". Surg Endosc. 22 (4): 821–48. doi:10.1007/s00464-007-9735-5. PMID 18293036.
  6. Loffroy, R; Rao, P; Kwak, BK; Ota, S; De Lin, M; Liapi, E; Geschwind, JF (May–Jun 2010). "Transcatheter arterial [[embolization]] in patients with kidney diseases: an overview of the technical aspects and clinical indications" (PDF). Korean journal of radiology : official journal of the Korean Radiological Society. 11 (3): 257–68. doi:10.3348/kjr.2010.11.3.257. PMC 2864852. PMID 20461179. URL–wikilink conflict (help)


Template:WikiDoc Sources